Concepedia

Jessica Valencia

JV

6

Publications

507

Citations

6

H-Index

2003

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis (United States)

Rutgers, The State University of New Jersey

Tris Pharma (United States)

Jessica Valencia is an author at Novartis (Switzerland) specializing in medicine, glycobiology, and drug discovery.

Top concepts

Publications per year

2003–2014

6

Publications

6

Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics

Jessica Valencia, Stephen C. Weldon, Douglas Quinn et al. · Analytical Biochemistry · 2003 · 177 citations

, , +9

Absorption, Distribution, Metabolism, and Elimination of the Direct Renin Inhibitor Aliskiren in Healthy Volunteers

Felix Waldmeier, Ulrike Glaenzel, B. Wirz et al. · Drug Metabolism and Disposition · 2007 · 127 citations

Divergent Pathways of Gene Expression Are Activated by the RAGE Ligands S100b and AGE-BSA

Jessica Valencia, Manisha Mone, Jin Zhang et al. · Diabetes · 2004 · 90 citations · Full text

, , +24

Lack of pharmacokinetic interactions of aliskiren, a novel direct renin inhibitor for the treatment of hypertension, with the antihypertensives amlodipine, valsartan, hydrochlorothiazide (HCTZ) and ramipril in healthy volunteers

Sujata Vaidyanathan, Jessica Valencia, Charisse Kemp et al. · International Journal of Clinical Practice · 2006 · 87 citations

Hormonal and metabolic effects of morning or evening dosing of the dipeptidyl peptidase IV inhibitor vildagliptin in patients with type 2 diabetes

Yanling He, Jessica Valencia, Yiming Zhang et al. · British Journal of Clinical Pharmacology · 2010 · 15 citations · Full text

Rows per page

1–5 of 6